To answer these questions, lets explore the science, benefits, and potential concerns around this practice
What is the patient's insulin resistance profile
GLP-1 receptor agonists and GLP-1 and glucose-dependent insulinotropic peptide agonists have several mechanisms of action, including reduction of gastric emptying, inhibition of glucagon secretion, beneficial changes in the intestinal microbiome, and direct effects on hypothalamic nuclei to enhance satiety (which promotes weight loss)
CVOTs have become a cornerstone in evaluating antidiabetic medications, mandated by regulatory agencies to ensure that these drugs do not exacerbate cardiovascular risk
That is the price of activating GLP-1 receptors
5-Amino-1MQ works through a different and more upstream metabolic pathway